14-day Premium Trial Subscription Sign Up For FreeGet Free
Nasdaq - Total Crash or Bounce-Up? Click To Watch.

$0.63 (5.00%)

Volume: 126.114k

Closed: Sep 30, 2022

Hollow Logo Score: -2.352

Akari Therapeutics Plc Stock Forecast

$0.63 (5.00%)

Volume: 126.114k

Closed: Sep 30, 2022

Score Hollow Logo -2.352

Akari Therapeutics Plc Stock Signals NASDAQ:AKTX

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -2.352 22 days ( 47.06 % )
Last Price $0.63 5.00 %
High/ Low $0.60 - $0.63 15.35%
Chg 7 Days 5.85 % $0.60 $0.63
Chg 30 Days -47.06 % $1.19 $0.63
Chg 12 mos -61.35 % $1.63 $0.63
Trend - 3 mos -18.64 % Width: 166.00 %
Trend - 12 mos -35.24 % Width: 175.06 %
Pred. range - 3 mos $0.43 - $1.14 -31.74 % - 81.56 %
Pred. range - 12 mos $0.35 - $0.96 -44.88 % - 51.60 %
Short mv avg 3 mos Buy 2022-09-27 - 4 days
Long mv avg 3 mos Sell 2022-08-30 - 23 days
Short/Long mv avg 3 mos Sell 2022-08-30 - 23 days
Short mv avg 12 mos Buy 2022-09-29 - 2 days
Long mv avg 12 mos Sell 2022-09-07 - 18 days
Short/Long mv avg 12 mos Sell 2022-09-09 - 16 days
Pivot Short Sell 2022-09-26 - 5 days
Bollinger Buy 2022-07-15 - 55 days
MACD Buy No Dates Stored For This Signal

AKTX splits

Date Ratio Status
2015-09-17 1:10 Applied

Hot Stocks To Watch:

About Akari Therapeutics Plc

Akari Therapeutics Plc Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-Barré syndrome, hematopoietic stem cell transplant-associated thrombotic microangiopathy, and bullous ... AKTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT